[et_pb_section fb_built=”1″ admin_label=”Home 2 Content Pg” _builder_version=”4.16″ _module_preset=”default” background_color=”#bbe4ed” background_image=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2022\/02\/rsz-tnc-header-engagement-1000×200-1.jpg” background_size=”initial” width_phone=”auto” width_last_edited=”off|desktop” max_width_last_edited=”off|desktop” module_alignment=”center” min_height_tablet=”300px” min_height_last_edited=”off|desktop” height=”200px” height_tablet=”154px” height_phone=”100px” height_last_edited=”on|phone” max_height_tablet=”300px” max_height_phone=”300px” max_height_last_edited=”off|desktop” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” top_divider_height_tablet=”” top_divider_height_phone=”50px” top_divider_height_last_edited=”on|phone” bottom_divider_style=”curve” bottom_divider_color=”#FFFFFF” bottom_divider_height=”70px” bottom_divider_arrangement=”above_content” bottom_divider_height_tablet=”70px” bottom_divider_height_phone=”50px” bottom_divider_height_last_edited=”on|desktop” background_last_edited=”on|tablet” background_image_phone=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2022\/02\/rsz-tnc-mobile-stars.jpg” background_enable_image_phone=”on” parallax_tablet=”off” parallax_phone=”off” background_size_tablet=”contain” background_size_phone=”initial” background_position_tablet=”top_center” background_position_phone=”top_right” background_enable_video_mp4_tablet=”off” background_enable_video_mp4_phone=”off” module_alignment_tablet=”right” module_alignment_phone=”left” module_alignment_last_edited=”off|desktop” locked=”off” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ use_custom_gutter=”on” gutter_width=”1″ _builder_version=”4.16″ _module_preset=”default” module_alignment=”center” custom_margin=”0px||||false|false” custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text content_tablet=”<\/p>\n
” content_phone=”<\/p>\n
” content_last_edited=”on|phone” _builder_version=”4.27.0″ _module_preset=”default” z_index=”10″ custom_margin=”30px||||false|false” custom_margin_tablet=”30px||||false|false” custom_margin_phone=”|0%|||false|false” custom_margin_last_edited=”on|phone” custom_padding=”|187px|||false|false” custom_padding_tablet=”|427px|||false|false” custom_padding_phone=”|0px|||false|false” custom_padding_last_edited=”on|desktop” hover_enabled=”0″ locked=”off” global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n
[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” background_enable_color=”off” custom_margin=”20px||21px||false|false” custom_padding=”0px||0px||false|false” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” custom_padding=”0px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_id=”sma” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#ededed” custom_margin=”||||false|false” custom_padding=”40px||2px||false|false” locked=”off” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ use_custom_gutter=”on” gutter_width=”2″ _builder_version=”4.20.2″ _module_preset=”default” custom_padding=”0px|0px|30px|0px|false|false” locked=”off” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2022\/02\/logo-cure-sma-400X296.png” alt=”CureSMA Logo” title_text=”logo-cure-sma-400X296″ url=”https:\/\/www.curesma.org\/” url_new_window=”on” _builder_version=”4.16″ _module_preset=”0c026c7a-5762-4696-9e59-ca7bc7f580ed” max_width=”50%” max_width_tablet=”25%” max_width_phone=”50%” max_width_last_edited=”on|desktop” module_alignment=”center” module_alignment_tablet=”left” module_alignment_phone=”left” module_alignment_last_edited=”on|desktop” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
CureSMA funds and directs research paving the way for treatment and care for those affected by spinal muscular atrophy, while also promoting a supportive community. Through collaborative endeavors between researchers, practitioners, families, and the patients themselves, CureSMA takes a comprehensive approach to their strategy of developing a treatment.<\/p>\n
LEARN MORE ><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_id=”mda” _builder_version=”4.19.2″ _module_preset=”default” background_color=”#ededed” custom_margin=”||||false|false” custom_padding=”0px||0px||true|false” locked=”off” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”0px|auto||auto|false|false” custom_padding=”20px|30px|0px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” text_letter_spacing=”6px” custom_margin=”||16px|||” global_colors_info=”{}”]<\/p>\n CLINICAL TRIAL<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n Learn More ><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”0px|auto|10px|auto|false|false” custom_padding=”0px|30px|30px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” link_text_color=”#0C71C3″ custom_margin=”||-2px|||” custom_padding=”||||false|false” global_colors_info=”{}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#FFFFFF”]<\/p>\n PI: Basil Darras, MD\u00a0 |\u00a0 Clinical Drug Trial \u2014 NCT04089566 ><\/a> [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”30px|auto||auto|false|false” custom_padding=”20px|30px|0px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” text_letter_spacing=”6px” custom_margin=”||16px|||” global_colors_info=”{}”]<\/p>\n CLINICAL TRIAL<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” locked=”off” global_colors_info=”{}”]<\/p>\n Learn More ><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”0px|auto|10px|auto|false|false” custom_padding=”0px|30px|30px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” link_text_color=”#0C71C3″ custom_margin=”||-2px|||” custom_padding=”||||false|false” global_colors_info=”{}” link_text_color__hover=”#FFFFFF” link_text_color__hover_enabled=”on|hover”]<\/p>\n PI: Basil Darras, MD\u00a0 |\u00a0 Clinical Drug Trial \u2014 NCT04851873 ><\/a> CLINICAL TRIAL<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n Learn More ><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”0px|auto|10px|auto|false|false” custom_padding=”0px|30px|30px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” link_text_color=”#0C71C3″ custom_margin=”||-2px|||” custom_padding=”||||false|false” global_colors_info=”{}” link_text_color__hover=”#FFFFFF” link_text_color__hover_enabled=”on|hover”]<\/p>\n PI: Basil Darras, MD\u00a0 |\u00a0 Clinical Drug Trial \u2014 NCT02913482 ><\/a> CLINICAL TRIAL<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n Learn More ><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”0px|auto|10px|auto|false|false” custom_padding=”0px|30px|30px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” link_text_color=”#0C71C3″ custom_margin=”||-2px|||” custom_padding=”||||false|false” global_colors_info=”{}” link_text_color__hover=”#FFFFFF” link_text_color__hover_enabled=”on|hover”]<\/p>\n PI: Basil Darras, MD\u00a0 |\u00a0 Clinical Drug Trial \u2014 NCT03032172 ><\/a> CLINICAL TRIAL<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n Learn More ><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”0px|auto|10px|auto|false|false” custom_padding=”0px|30px|30px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” link_text_color=”#0C71C3″ custom_margin=”||-2px|||” custom_padding=”||||false|false” global_colors_info=”{}” link_text_color__hover=”#FFFFFF” link_text_color__hover_enabled=”on|hover”]<\/p>\n PI: Basil Darras, MD\u00a0 |\u00a0 Clinical Drug Trial \u2014 NCT05115110 ><\/a> CLINICAL TRIAL<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n Learn More ><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”0px|auto|10px|auto|false|false” custom_padding=”0px|30px|30px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” link_text_color=”#0C71C3″ custom_margin=”||-2px|||” custom_padding=”||||false|false” global_colors_info=”{}” link_text_color__hover=”#FFFFFF” link_text_color__hover_enabled=”on|hover”]<\/p>\n PI: Basil Darras, MD\u00a0 |\u00a0 Clinical Drug Trial \u2014 NCT03921528 ><\/a> For PatientsPartnership for Spinal Muscular Atrophy (SMA)CureSMA CureSMA funds and directs research paving the way for treatment and care for those affected by spinal muscular atrophy, while also promoting a supportive community. Through collaborative endeavors between researchers, practitioners, families, and the patients themselves, CureSMA takes a comprehensive approach to their strategy of developing a treatment. […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":8782,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-11203","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/pages\/11203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/comments?post=11203"}],"version-history":[{"count":5,"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/pages\/11203\/revisions"}],"predecessor-version":[{"id":12207,"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/pages\/11203\/revisions\/12207"}],"up":[{"embeddable":true,"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/pages\/8782"}],"wp:attachment":[{"href":"https:\/\/epitomestaging.com\/tnc\/wp-json\/wp\/v2\/media?parent=11203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy (DEVOTE)<\/h3>\n
Patient Advocacy Group Partners: Cure SMA<\/a>, Muscular Dystrophy Association<\/a><\/p>\nSafety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) (SMART)<\/h3>\n
\nPatient Advocacy Group Partners: Cure SMA<\/a>, Muscular Dystrophy Association<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”30px|auto||auto|false|false” custom_padding=”20px|30px|0px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” text_letter_spacing=”6px” custom_margin=”||16px|||” global_colors_info=”{}”]<\/p>\nInvestigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy (FIREFISH)<\/h3>\n
\nPatient Advocacy Group Partners: Cure SMA<\/a>, Muscular Dystrophy Association<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”30px|auto||auto|false|false” custom_padding=”20px|30px|0px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” text_letter_spacing=”6px” custom_margin=”||16px|||” global_colors_info=”{}”]<\/p>\nA Study of Risdiplam (RO7034067) in Adult and Pediatric Participants With Spinal Muscular Atrophy (Jewelfish)<\/h3>\n
\nPatient Advocacy Group Partners: Cure SMA<\/a>, Muscular Dystrophy Association<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”30px|auto||auto|false|false” custom_padding=”20px|30px|0px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” text_letter_spacing=”6px” custom_margin=”||16px|||” global_colors_info=”{}”]<\/p>\nA Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Ambulatory Children With Spinal Muscular Atrophy<\/h3>\n
\nPatient Advocacy Group Partners: Cure SMA<\/a>, Muscular Dystrophy Association<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.20.4″ _module_preset=”default” background_color=”#bbe4ed” custom_margin=”30px|auto||auto|false|false” custom_padding=”20px|30px|0px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” text_letter_spacing=”6px” custom_margin=”||16px|||” global_colors_info=”{}”]<\/p>\nAn Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy (TOPAZ)<\/h3>\n
\nPatient Advocacy Group Partners: Cure SMA<\/a>, Muscular Dystrophy Association<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"